StockData
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. (KRYS) stock

KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$297.90−7.33 (-2.40%)

Close on Nov 16, 2026Market cap $8.82BP/E 37.3Yield –

Krystal Biotech cash

Cash and short-term investments held at the end of each period.

Krystal Biotech's cash was $845.60M at Jun 30, 2026. For fiscal 2025 it was $827.80M, up 38.5% from the year before. The highest annual figure on record is $827.80M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$827.80M+38.5%
FY2024Dec 31, 2024$597.50M+12.3%
FY2023Dec 31, 2023$532.20M+40.3%
FY2022Dec 31, 2022$379.20M-13.4%
FY2021Dec 31, 2021$438.10M+61.5%
FY2020Dec 31, 2020$271.30M+40.1%
FY2019Dec 31, 2019$193.70M+73.3%
FY2018Dec 31, 2018$111.76M+125.4%
FY2017Dec 31, 2017$49.59M+2478.8%
FY2016Dec 31, 2016$1.92M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$845.60M+24.0%
Q1 FY2026Mar 31, 2026$823.40M+33.5%
Q4 FY2025Dec 31, 2025$827.80M+38.5%
Q3 FY2025Sep 30, 2025$731.10M+24.3%
Q2 FY2025Jun 30, 2025$682.00M+21.9%
Q1 FY2025Mar 31, 2025$616.80M+14.6%
Q4 FY2024Dec 31, 2024$597.50M+12.3%
Q3 FY2024Sep 30, 2024$588.30M+4.7%
Q2 FY2024Jun 30, 2024$559.60M+17.2%
Q1 FY2024Mar 31, 2024$538.30M+53.6%
Q4 FY2023Dec 31, 2023$532.20M+40.3%
Q3 FY2023Sep 30, 2023$562.10M+42.5%
Q2 FY2023Jun 30, 2023$477.50M+12.2%
Q1 FY2023Mar 31, 2023$350.40M-19.4%
Q4 FY2022Dec 31, 2022$379.20M-13.4%
Q3 FY2022Sep 30, 2022$394.40M+15.0%
Q2 FY2022Jun 30, 2022$425.60M+15.7%
Q1 FY2022Mar 31, 2022$434.60M+7.7%
Q4 FY2021Dec 31, 2021$438.10M+61.5%
Q3 FY2021Sep 30, 2021$343.10M+19.8%
Q2 FY2021Jun 30, 2021$367.70M+23.7%
Q1 FY2021Mar 31, 2021$403.40M+116.1%
Q4 FY2020Dec 31, 2020$271.30M+40.1%
Q3 FY2020Sep 30, 2020$286.40M+40.9%
Q2 FY2020Jun 30, 2020$297.20M+52.0%
Q1 FY2020Mar 31, 2020$186.70M+75.1%
Q4 FY2019Dec 31, 2019$193.70M+73.3%
Q3 FY2019Sep 30, 2019$203.20M+288.5%
Q2 FY2019Jun 30, 2019$195.50M+329.7%
Q1 FY2019Mar 31, 2019$106.60M+125.7%
Q4 FY2018Dec 31, 2018$111.76M+125.4%
Q3 FY2018Sep 30, 2018$52.30M-0.5%
Q2 FY2018Jun 30, 2018$45.50M+1193.3%
Q1 FY2018Mar 31, 2018$47.23M+2356.0%
Q4 FY2017Dec 31, 2017$49.59M+2478.8%
Q3 FY2017Sep 30, 2017$52.57M+13108.5%
Q2 FY2017Jun 30, 2017$3.52M–
Q1 FY2017Mar 31, 2017$1.92M–
Q4 FY2016Dec 31, 2016$1.92M–
Q3 FY2016Sep 30, 2016$398.00K–

More Krystal Biotech figures

See a number that looks wrong?